AbbVie: Citigroup Raises Target Price to $260 From $230
ABBV•Related News
Morgan Stanley profit rises on dealmaking boost
MS•
Green Thumb raises shareholder meeting quorum requirement to 33.33% from 5%
GTBIF•
Morgan Stanley says Q2 2026 earnings results release is available on investor relations website
MS•
KE Holdings files HKEX next-day disclosure return reporting share repurchase for cancellation
BEKE•
JPMorgan <JPM.N>: Truist Securities raises target price to $352 from $344
JPM•